Adam Torbicki

Q: What Schools Are Affiliated With Adam Torbicki

Adam Torbicki is affiliated with the following schools: University of Perugia, Medical University of Warsaw, Centre of Medical Postgraduate Education

Adam Torbicki's AcademicInfluence.com Rankings

Adam Torbicki

Philosophy

#7076

World Rank

#10233

Historical Rank

Logic

#4153

World Rank

#5411

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Adam Torbicki's Degrees

Doctorate Medicine Medical University of Warsaw
PhD Cardiology Medical University of Warsaw

Why Is Adam Torbicki Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Adam Torbicki's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). (2013) (6036)
ESC / EACTS Guidelines on myocardial revascularization (2012) (5643)
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 (2010) (4824)
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. (2013) (3723)
2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous (2014) (3302)
Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). (2008) (2897)
2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension. (2016) (2682)
[2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension]. (2015) (2327)
2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). (2013) (2221)
ESC Guidelines on the diagnosis and management of acute pulmonary embolism (2014) (2085)
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension (2015) (2007)
2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. (2014) (1978)
Sildenafil citrate therapy for pulmonary arterial hypertension. (2005) (1939)
ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conference (2001) (1865)
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). (2016) (1844)
Guidelines for the diagnosis and treatment of pulmonary hypertension (2009) (1630)
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) (2019) (1493)
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). (2020) (1486)
2015 ESC Guidelines for the diagnosis and management of pericardial diseases (2015) (1246)
Macitentan and morbidity and mortality in pulmonary arterial hypertension. (2013) (1116)
Fibrinolysis for patients with intermediate-risk pulmonary embolism. (2014) (1108)
Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. (2004) (1056)
Diagnosis and differential assessment of pulmonary arterial hypertension. (2004) (999)
2018 ESC Guidelines for the diagnosis and management of syncope (2018) (942)
Editor's Choice - 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). (2018) (811)
Chronic Thromboembolic Pulmonary Hypertension (CTEPH): Results From an International Prospective Registry (2011) (805)
The 2013 ESH/ESC guidelines for the management of arterial hypertension (2013) (805)
Third universal definition of myocardial infarction. (2012) (751)
Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology. (2013) (750)
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines (2016) (738)
Diagnosis and assessment of pulmonary arterial hypertension. (2009) (693)
Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial. (2002) (636)
[Guidelines on the diagnosis and management of acute pulmonary embolism]. (2009) (532)
Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial. (2008) (522)
Management of grown up congenital heart disease. (2003) (498)
Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer. (2020) (484)
213 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy (2013) (484)
Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study. (2004) (476)
Right heart thrombi in pulmonary embolism: results from the International Cooperative Pulmonary Embolism Registry. (2003) (455)
Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension. (2009) (417)
Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension: Results From an International Prospective Registry (2016) (415)
Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and doppler measures in patients with pulmonary arterial hypertension. (2003) (384)
Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension. (2006) (376)
The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) Endorsed by the European Respiratory Society (ERS) (2014) (372)
Mutations of the TGF‐β type II receptor BMPR2 in pulmonary arterial hypertension (2006) (344)
Management of venous thrombo-embolism: an update. (2014) (317)
Detectable Serum Cardiac Troponin T as a Marker of Poor Prognosis Among Patients With Chronic Precapillary Pulmonary Hypertension (2003) (314)
Efficacy and Safety of Oral Treprostinil Monotherapy for the Treatment of Pulmonary Arterial Hypertension: A Randomized, Controlled Trial (2013) (282)
Selexipag: an oral, selective prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension (2012) (278)
The pathophysiology of chronic thromboembolic pulmonary hypertension (2017) (261)
Cardiac troponin T monitoring identifies high-risk group of normotensive patients with acute pulmonary embolism. (2003) (240)
Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European Society of Cardiology working groups of aorta and peripheral vascular diseases and pulmonary circulation and right ventricular function. (2018) (236)
Pregnancy outcomes in pulmonary arterial hypertension in the modern management era (2012) (226)
Noninvasive diagnosis of suspected severe pulmonary embolism: transesophageal echocardiography vs spiral CT. (1997) (223)
N‐terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism (2003) (217)
Stress Doppler Echocardiography in Relatives of Patients With Idiopathic and Familial Pulmonary Arterial Hypertension: Results of a Multicenter European Analysis of Pulmonary Artery Pressure Response to Exercise and Hypoxia (2009) (217)
Erratum: 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism (European Heart Journal (2014) 35 (3033-73) DOI 10.1093/eurheartj/ehu283) (2015) (210)
Diagnosis of pulmonary hypertension (2019) (189)
End points and clinical trial designs in pulmonary arterial hypertension: clinical and regulatory perspectives. (2004) (188)
[Guidelines on diagnosis and treatment of pulmonary arterial hypertension]. (2005) (178)
[2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism]. (2014) (174)
ERS statement on chronic thromboembolic pulmonary hypertension (2020) (166)
Atrial septostomy in treatment of end-stage right heart failure in patients with pulmonary hypertension. (2007) (162)
Outcome after cardiopulmonary resuscitation in patients with pulmonary arterial hypertension. (2002) (158)
Guía ESC/ERS 2015 sobre diagnóstico y tratamiento de la hipertensión pulmonar (2016) (156)
[2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines]. (2016) (155)
Doppler echocardiographic evaluation of pulmonary artery pressure in chronic obstructive pulmonary disease. A European multicentre study. Working Group on Noninvasive Evaluation of Pulmonary Artery Pressure. European Office of the World Health Organization, Copenhagen. (1991) (151)
More on the noninvasive diagnosis of pulmonary hypertension: Doppler echocardiography revisited. (1995) (148)
Disturbed right ventricular ejection pattern as a new Doppler echocardiographic sign of acute pulmonary embolism. (2002) (144)
Left atrial appendage dysfunction: a cause of thrombosis? Evidence by transesophageal echocardiography-Doppler studies. (1991) (135)
Practical Instructions for the 2018 ESC Guidelines for the diagnosis and management of syncope (2018) (121)
Management of Grown Up Congenital Heart Disease The Task Force on the Management of Grown Up Congenital Heart Disease of the European Society of Cardiology (2003) (121)
Guía ESC 2016 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica (2016) (113)
Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension (2015) (111)
Apixaban versus Dalteparin for the Treatment of Acute Venous Thromboembolism in Patients with Cancer: The Caravaggio Study (2018) (108)
Diagnostic value of transoesophageal echocardiography in suspected haemodynamically significant pulmonary embolism (2001) (107)
Factors associated with diagnosis and operability of chronic thromboembolic pulmonary hypertension (2013) (105)
Changes in Bone Density during Long-Term Administration of Low-Molecular-Weight Heparins or Acenocoumarol for Secondary Prophylaxis of Venous Thromboembolism (2003) (102)
Proximal pulmonary emboli modify right ventricular ejection pattern. (1999) (98)
Pulmonary artery dilatation correlates with the risk of unexpected death in chronic arterial or thromboembolic pulmonary hypertension. (2012) (98)
Expert consensus document on management of cardiovascular diseases during pregnancy The Task Force on the Management of Cardiovascular Diseases During Pregnancy of the European Society of Cardiology (2003) (95)
Erratum : 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension (2015) (94)
Diagnosis, treatment, and prevention of pulmonary embolism : report of the WHO/international society and federation of cardiology task force (1992) (92)
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD The Task Force on diabetes, pre-diabetes, and cardiovascular diseases of theEuropeanSocietyofCardiology(ESC)anddevelopedincollaboration (2014) (91)
Subcutaneous treprostinil for the treatment of severe non-operable chronic thromboembolic pulmonary hypertension (CTREPH): a double-blind, phase 3, randomised controlled trial. (2019) (80)
Attempts at measuring pulmonary arterial pressure by means of Doppler echocardiography in patients with chronic lung disease. (1989) (80)
Outcome of patients with right heart thrombi: the Right Heart Thrombi European Registry (2016) (79)
Pulmonary Arterial Hypertension-Related Morbidity Is Prognostic for Mortality. (2018) (77)
Amiodarone in restoration and maintenance of sinus rhythm in patients with chronic atrial fibrillation after unsuccessful direct‐current cardioversion (1997) (70)
Endothelin-1 Pathway Polymorphisms and Outcomes in Pulmonary Arterial Hypertension. (2015) (67)
Detection of patients at risk for recurrence of atrial fibrillation after successful electrical cardioversion by signal-averaged P-wave ECG. (1997) (66)
Effect of macitentan on hospitalizations: results from the SERAPHIN trial. (2015) (61)
The role of echocardiography in the diagnosis and management of patients with pulmonary hypertension (2010) (59)
Balloon pulmonary angioplasty for the treatment of residual or recurrent pulmonary hypertension after pulmonary endarterectomy. (2019) (57)
Characteristics and prognosis of patients with decompensated right ventricular failure during the course of pulmonary hypertension. (2008) (57)
Transoesophageal echocardiography for definitive diagnosis of haemodynamically significant pulmonary embolism. (1995) (54)
SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension (2017) (53)
Haemodynamic effects of pressure support and PEEP ventilation by nasal route in patients with stable chronic obstructive pulmonary disease. (1993) (53)
Prognostic Significance of Right Heart Thrombi in Patients With Acute Symptomatic Pulmonary Embolism: Systematic Review and Meta‐analysis (2017) (52)
Summary of recommendations for the haemodynamic and angiographic assessment of the pulmonary circulation. Joint statement of the Polish Cardiac Society's Working Group on Pulmonary Circulation and Association of Cardiovascular Interventions. (2015) (51)
Cardiac magnetic resonance in pulmonary arterial hypertension: a step in the right direction. (2007) (50)
Pre-existing arterial hypertension as a risk factor for early left ventricular systolic dysfunction following (R)-CHOP chemotherapy in patients with lymphoma. (2014) (48)
Rhythm control versus rate control in patients with persistent atrial fibrillation. Results of the HOT CAFE Polish Study. (2003) (44)
Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHIN (2015) (44)
Macitentan Improves Health‐Related Quality of Life for Patients With Pulmonary Arterial Hypertension: Results From the Randomized Controlled SERAPHIN Trial (2017) (44)
Improvement in Quality of Life and Hemodynamics in Chronic Thromboembolic Pulmonary Hypertension Treated With Balloon Pulmonary Angioplasty. (2017) (43)
Balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension. (2013) (41)
In-hospital major bleeding predicts mortality in patients with pulmonary embolism: an analysis of ZATPOL Registry data. (2013) (37)
Short term clinical outcome of acute saddle pulmonary embolism (2003) (36)
Guías de Práctica Clínica sobre el diagnóstico y tratamiento de la hipertensión arterial pulmonar (2005) (36)
Proof-Of-Concept Study To Investigate The Efficacy, Hemodynamics And Tolerability Of Terguride Vs. Placebo In Subjects With Pulmonary Arterial Hypertension: Results Of A Double Blind, Randomised, Prospective Phase IIa Study (2012) (36)
Characterization of Patients with Pulmonary Arterial Hypertension: Data from the Polish Registry of Pulmonary Hypertension (BNP-PL) (2020) (36)
A comparison between the automatized impedance cardiography and pulsed-wave Doppler echocardiography methods for measurements of stroke volume (SV) and systolic time intervals (STI). (1993) (36)
Effects Of Inhaled Aviptadil (Vasoactive Intestinal Peptide) In Patients With Pulmonary Arterial Hypertension (PAH) (2010) (34)
Changing the strategy of balloon pulmonary angioplasty resulted in a reduced complication rate in patients with chronic thromboembolic pulmonary hypertension. A single-centre European experience. (2017) (34)
Safety and efficacy of sitaxsentan 50 and 100 mg in patients with pulmonary arterial hypertension. (2012) (33)
Myoglobin stratifies short-term risk in acute major pulmonary embolism. (2003) (33)
Recurrent hemoptysis: an emerging life-threatening complication in idiopathic pulmonary arterial hypertension. (2011) (32)
Corrigendum to: 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism. (2015) (31)
Association between six-minute walk distance and long-term outcomes in patients with pulmonary arterial hypertension: Data from the randomized SERAPHIN trial (2018) (30)
Long‐term effects of acute pulmonary embolism on echocardiographic doppler indices and functional capacity (2004) (30)
Guía de práctica clínica de la ESC para el manejo del infarto agudo de miocardio en pacientes con elevación del segmento ST (2013) (30)
Outcome of Medically Versus Surgically Treated Patients With Chronic Thromboembolic Pulmonary Hypertension (2016) (29)
Echocardiographic diagnosis of pulmonary embolism: a rise and fall of McConnell sign? (2005) (29)
Guía de práctica clínica para el diagnóstico y tratamiento de la hipertensión pulmonar (2009) (29)
Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension (2016) (29)
Update of screening and diagnostic modalities for connective tissue disease-associated pulmonary arterial hypertension. (2019) (28)
Right Heart Adaptation to Pulmonary ArterialHypertension (2013) (27)
Augmented reality and three-dimensional printing in percutaneous interventions on pulmonary arteries. (2019) (27)
Guía ESC 2017 sobre el diagnóstico y tratamiento de la enfermedad arterial periférica, desarrollada en colaboración con la European Society for Vascular Surgery (ESVS) (2018) (26)
Effect of Macitentan on Morbidity and Mortality in Pulmonary Arterial Hypertension (PAH): Results From the SERAPHIN Trial (2012) (26)
The role of echocardiography in suspected and established PE. (2001) (26)
Role of echo/doppler in the diagnosis of pulmonary embolism (1992) (25)
Proposed new pulmonary hypertension definition: is 4 mm(Hg) worth re-writing medical textbooks? (2019) (24)
Diagnostic utility of CYFRA 21-1 and CEA assays in pericardial fluid for the recognition of neoplastic pericarditis. (2005) (24)
Hemodynamic effects of negative-pressure ventilation in patients with COPD. (1990) (23)
Fatal primary pulmonary hypertension in a 30‐yr-old female with APECED syndrome (2003) (23)
Enfermedad tromboembólica pulmonar. Manejo clínico de la enfermedad aguda y crónica (2010) (23)
[Polish guidelines for the prevention and treatment of venous thromboembolism. 2012 update]. (2012) (22)
Right atrial mobile thrombi: two-dimensional echocardiographic diagnosis and clinical outcome. (1987) (21)
Management of pulmonary embolism: recent evidence and the new European guidelines (2014) (20)
An implantable pump Lenus pro® in the treatment of pulmonary arterial hypertension with intravenous treprostinil (2017) (19)
Sequential treatment with sildenafil and riociguat in patients with persistent or inoperable chronic thromboembolic pulmonary hypertension improves functional class and pulmonary hemodynamics. (2018) (19)
Treatment of chronic thromboembolic pulmonary hypertension in a multidisciplinary team (2019) (18)
Data Base of pulmoNary hyPertension in the PoLish population (BNP-PL) - design of the registry. (2019) (18)
[Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology]. (2014) (17)
Guía de práctica clínica de la ESC 2014 sobre el diagnóstico y el tratamiento de la embolia pulmonar aguda (2015) (17)
Apixaban and Dalteparin for the Treatment of Venous Thromboembolism in Patients with Different Sites of Cancer (2021) (17)
Guidelines for diagnosis and management of acute pulmonary embolism. Task force report (2000) (16)
Guía de práctica clínica de la ESC sobre revascularización miocárdica, 2014 (2015) (16)
Acute and long term management of pulmonary embolism (2010) (16)
Extended Anticoagulant Treatment with Full- or Reduced-Dose Apixaban in Patients with Cancer-Associated Venous Thromboembolism: Rationale and Design of the API-CAT Study (2021) (15)
Noninvasive diagnosis and treatment of a saddle pulmonary embolism. A case report in support of new trends in management of pulmonary embolism. (1996) (15)
Characteristics and outcomes of patients with chronic thromboembolic pulmonary hypertension in the era of modern therapeutic approaches: data from the Polish multicenter registry (BNP-PL) (2021) (15)
A decrease of enlarged left atrium following cardioversion of atrial fibrillation predicts the long-term maintenance of sinus rhythm. (2005) (15)
Guidance for anticoagulation management in venous thromboembolism during the coronavirus disease 2019 (COVID-19) pandemic in Poland: an expert opinion of the Section on Pulmonary Circulation of the Polish Cardiac Society. (2020) (15)
[Polish guidelines for the prevention and treatment of venous thromboembolism: 2009 update]. (2009) (15)
Evaluation of Tp-e interval and Tp-e/QT ratio in patients with rheumatoid arthritis. (2014) (14)
Expert opinion on the creating and operating of the regional Pulmonary Embolism Response Teams (PERT). Polish PERT Initiative. (2020) (14)
Long-term sinus rhythm maintenance after cardioversion of persistent atrial fibrillation: is the treatment's success predictable? (2006) (14)
Predictive value of RT-PCR PML-RARA transcript monitoring for extramedullary relapse of acute promyelocytic leukemia in the pleura, heart and pericardium after allogeneic SCT. (2007) (13)
Fear of COVID-19, Anxiety and Depression in Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension during the Pandemic (2021) (13)
Pulmonary thromboembolic disease. Clinical management of acute and chronic disease. (2010) (13)
Pulmonary arterial hypertension: new ideas and perspectives (2001) (12)
Pulmonary arterial hypertension: evaluation of the newly diagnosed patient. (2005) (12)
Prostacyclin Analogues Inhibit Platelet Reactivity, Extracellular Vesicle Release and Thrombus Formation in Patients with Pulmonary Arterial Hypertension (2021) (12)
[Polish forum for prevention guidelines on cardiovascular risk assessment]. (2007) (12)
Acute and chronic dissection of pulmonary artery: new challenges in pulmonary arterial hypertension? (2017) (12)
Echocardiography in pulmonary embolism (1994) (12)
Cardiac troponins in acute pulmonary embolism. (2002) (11)
Hypertension: Definition of pulmonary hypertension challenged? (2016) (11)
Functional class and type of pulmonary hypertension determinate severity of cardiac autonomic dysfunction assessed by heart rate variability and turbulence. (2015) (11)
Value of M-mode echocardiography in assessing pulmonary arterial pressure in patients with chronic lung disease. (1987) (10)
Left main artery compression by pulmonary artery aneurysm and ostial athero-stenosis of left anterior descending artery in a young female with pulmonary arterial hypertension. (2012) (10)
FREEDOM-M: Efficacy and Safety of Oral Treprostinil Diethanolamine as Monotherapy in Patients With Pulmonary Arterial Hypertension (2011) (10)
Severity of Arterial and Chronic Thromboembolic Pulmonary Hypertension is Associated with Impairment of Heart Rate Turbulence (2015) (10)
Efficacy, Safety And Tolerability Of ACT-293987, A Novel Oral, Non-prostanoid, Prostaglandin I2 (IP) Receptor Agonist: Results From A Phase IIa Study In Pulmonary Arterial Hypertension (PAH) (2010) (9)
Role of cardiac biomarkers in assessment of RV function and prognosis in chronic pulmonary hypertension (2007) (9)
The REPAIR Study (2021) (9)
Changes in Estimated Glomerular Filtration after Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension (2019) (9)
Corrigendum to: 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism. (2015) (9)
Neurohormonal modulation in right ventricular failure (2007) (8)
Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Hypertension: A Multicenter Registry. (2021) (8)
Low-Molecular-Weight Heparins, Acenocoumarol and Bone Density (2001) (8)
Assessing the severity of acute pulmonary embolism: back to the future? (2019) (8)
[Autoimmune thyroid diseases in patients with primary pulmonary hypertension]. (2008) (8)
Low DLCO in idiopathic pulmonary arterial hypertension - clinical correlates and prognostic significance. (2016) (8)
Imaging Venous Thromboembolism with Emphasis on Ultrasound, Chest CT, Angiography and Echocardiography (1999) (8)
Balloon Pulmonary Angioplasty in Technically Operable and Technically Inoperable Chronic Thromboembolic Pulmonary Hypertension (2021) (8)
The recurrence after ten years - "mother in-law variant" of tako-tsubo syndrome. (2010) (8)
Management of venous thromboembolism : an update (2014) (8)
Reliability of Pulsed Wave Doppler Monitoring of Acute Changes in Pulmonary Artery Pressure in Patients with Chronic Obstructive Pulmonary Disease (1990) (7)
Effect of macitentan on haemodynamics in SERAPHIN, a randomised controlled trial in pulmonary arterial hypertension (PAH) (2013) (7)
Pulmonary embolism: role of echocardiography and of biological markers. (2005) (7)
[Role of echocardiography in monitoring of cardiac toxicity of cancer pharmacotherapy. Expert consensus statement of the Polish Clinical Forum for Cardiovascular Imaging]. (2014) (7)
Macitentan reduces the risk of morbidity and mortality irrespective of the presence or absence of right ventricular (RV) impairment: Results from the randomised SERAPHIN trial in pulmonary arterial hypertension (PAH) (2014) (7)
Soluble ST2 as a Biomarker for Early Complications in Patients with Chronic Thromboembolic Pulmonary Hypertension Treated with Balloon Pulmonary Angioplasty (2021) (7)
Functional class and type of pulmonary hypertension determinate severity (2015) (6)
Results from the REPAIR Study Final Analysis: Effects of Macitentan on Right Ventricular (RV) Remodelling in Pulmonary Arterial Hypertension (PAH). (2020) (6)
Contemporary methods for the treatment of pulmonary embolism - is it prime-time for percutaneous interventions? (2017) (6)
[Value of spiral computed tomography in pulmonary hypertension]. (2004) (6)
Pregnancy as a predictor of deviations from the recommended diagnostic pathway in women with suspected pulmonary embolism: ZATPOL registry data (2017) (6)
Polish Forum for Prevention Guidelines on the so-called new cardiovascular risk factors and markers, which have a potentially significant role in the strategy for the prevention of cardiovascular diseases. (2007) (6)
Assessment of electrocardiographic markers of acute and long‐term hemodynamic improvement in patients with pulmonary hypertension (2020) (6)
Efficacy and Safety of Oral Treprostinil Monotherapy for the Treatment of Pulmonary Arterial Hypertension (6)
The evolution of electrocardiographic signs of right ventricular overload after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension. (2019) (6)
Centrilobular nodules in high resolution computed tomography of the lung in IPAH patients - preliminary data concerning clinico-radiological correlates. (2016) (6)
Integrating Data From Randomized Controlled Trials and Observational Studies to Assess Survival in Rare Diseases (2019) (6)
[Abnormalities in high-resolution computed tomography of the lungs in patients with idiopathic pulmonary arterial hypertension -- correlation with hemodynamic parameters and prognostic significance]. (2008) (6)
COVID-19 and pulmonary embolism: an unwanted alliance (2020) (6)
Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension (2016) (5)
Factors determining long-term maintenance of sinus rhythm after cardioversion of persistent atrial fibrillation. (2003) (5)
Effect of Increased Right Ventricular Preload on Pulmonary Artery Flow Velocity Pattern in Patients with Normal or Increased Pulmonary Artery Pressure (1994) (5)
Report from Session III of the Second International Colloquium on Cardio-oncology: Cardio-oncological management of patients. (2019) (5)
Determinants of Survival After Emergency Intrapericardial Cisplatin Treatment in Cancer Patients with Recurrent Hemodynamic Instability After Pericardiocentesis. (2018) (5)
Circulating Blood-Based Biomarkers in Pulmonary Hypertension (2022) (5)
[Recombinant hirudine in suspected heparin induced thrombocytopenia--case report of pulmonary embolism]. (2000) (5)
Polish forum for prevention guidelines on cardiovascular diseases prevention in women. (2007) (5)
Right ventricular myocardial oxygen tension is reduced in monocrotaline-induced pulmonary hypertension in the rat and restored by myo-inositol trispyrophosphate (2021) (5)
[Normal D-dimer concentration in hospitalized patients with lung diseases]. (2012) (5)
Guía de práctica clínica para el diagnóstico y tratamiento de la hipertensión pulmonar1 (2009) (5)
In search of markers of treatment failure and poor prognosis in IPAH - the value of mosaic lung attenuation pattern on thin-section CT scans (2010) (5)
Prognostic staging of acute pulmonary embolism: are we closer to the holy grail? (2014) (5)
[Should sinus rhythm be restored in patients with chronic atrial fibrillation? Preliminary results from the Polish "Hot Cafe" study]. (1999) (5)
Pulmonary Embolism Response Team - a multidisciplinary approach to pulmonary embolism treatment. Polish PERT Initiative Report. (2021) (5)
Atrial septostomy for severe primary pulmonary hypertension - report on two cases. (2003) (5)
Long-term Riociguat Treatment in Inoperable and Persistent/Recurrent CTEPH Patients in WHO Functional Class (FC) I/II Versus FC III/IV at Baseline: Results From the 16-Week Phase III CHEST-1 Study and CHEST-2 Open-Label Extension (2014) (4)
Guía de práctica clínica sobre el tratamiento de las valvulopatías (versión 2012) (2013) (4)
Soluble ST2 protein as a new biomarker in patientswith precapillary pulmonary hypertension (2020) (4)
More o on tthe n noninvasive d diagnosis o of p pulmonary hypertension: D Doppler e echocardiography rrevisited (1995) (4)
[Secondary anticoagulant prophylaxis with low molecular heparins or oral anticoagulants and bone mineral density]. (2000) (4)
Effect of Macitentan on Long-term Outcomes in Patients With Pulmonary Arterial Hypertension (PAH): Subanalysis of SERAPHIN Comparing Incident and Prevalent Patient Populations Not Treated With Background PAH-Specific Therapy (2013) (4)
[Pheochromocytoma with hemorrhagic necrosis and rupture with symptoms of acute abdomen and shock]. (1996) (4)
Impact of macitentan on the health-related quality of life (HRQoL) in pulmonary arterial hypertension (PAH): Results from a long-term randomised controlled trial (2013) (4)
Visualization of the central pulmonary arteries by biplane transesophageal echocardiography. (2001) (4)
Non-tuberculous mycobacterial lung disease (NT MLD ) in patients with chronic thromboembolic pulmonary hypertension and idiopathic pulmonary arterial hypertension. (2014) (4)
Balloon Pulmonary Angioplasty with Stent Implantation as a Treatment of Proximal Chronic Thromboembolic Pulmonary Hypertension (2020) (4)
Epidemiology and prevention Polish Forum for Prevention Guidelines on the Role of Alcohol Consumption in Cardiovascular Prevention (2006) (4)
Guía ESC 2019 para el diagnóstico y tratamiento de la embolia pulmonar aguda (2020) (4)
829 Care Organisation for Pulmonary Arterial Hypertension in Developed Countries: A Survey (2012) (4)
Association Between WHO Functional Class and Long-term Prognosis in Patients With Pulmonary Arterial Hypertension: Data From SERAPHIN, A Randomized Controlled Study of Macitentan (2013) (3)
Right ventricle in pulmonary hypertension: echocardiography strikes back? (2015) (3)
‘Syringe-in-the-Pocket’ – A New Approach to the Outpatient Thromboembolic Prophylaxis of Recurrent Atrial Fibrillation (2007) (3)
Effect of riociguat on pulmonary arterial compliance in the PATENT and CHEST studies (2020) (3)
[Detection of patent foramen ovale by transcranial Doppler ultrasonography]. (1994) (3)
Reduction Of Pulmonary Arterial Hypertension (Pah)-Related Hospitalizations With Macitentan In The Randomized Controlled Trial Seraphin (2013) (3)
Factors related to the early and late success of direct current cardioversion of chronic nonrheumatic atrial fibrillation: An echocardiographic study. (2001) (3)
The "bouncing" catheter. (2016) (3)
The multiple systemic artery to pulmonary artery fistulas resulting in severe irreversible pulmonary arterial hypertension in patient with previous history of pneumothorax (2019) (3)
[Recurrent effusive pericarditis in the course of adult-onset Still's disease--case reports of two patients]. (2011) (3)
[Effect of long-term therapy with oral Beraprost on survival of patients with arterial and inoperable thromboembolic pulmonary hypertension]. (2004) (3)
Pulmonary hypertension: diagnosis, differential diagnosis and pitfalls. (2012) (3)
Precision medicine: The future of diagnostic approach to pulmonary hypertension? (2019) (3)
Efficacy of sequential antiarrhythmic treatment in sinus rhythm maintenance after successful electrocardioversion in patients with chronic non-valvular atrial fibrillation. (2001) (3)
5017Subcutaneous treprostinil for the treatment of non-operable chronic thromboembolic pulmonary hypertension: a randomized, controlled trial (CTREPH) (2017) (3)
Using controlled and real-world data in concert to assess survival benefits in pulmonary arterial hypertension: Insights from SERAPHIN and REVEAL (2017) (3)
Prediction of Prognostic Hemodynamic Indices in Pulmonary Hypertension Using Non-Invasive Parameters (2020) (3)
Efficacy of riociguat in patients with inoperable CTEPH vs persistent/recurrent PH after pulmonary endarterectomy (PEA): Results from the phase III CHEST-1 study (2013) (3)
Sarcoidosis-associated pulmonary hypertension treated with sildenafil - a case report. (2017) (2)
Right Ventricular Myocardial Oxygen Partial Pressure Is Reduced in Monocrotaline-induced Pulmonary Hypertension in the Rat and Restored by Myo-inositol Trispyrophosphate (2021) (2)
Diagnostic Utility of Cyfra 21-1 and Cea Assays in Pericardial Fluid for the Recognition of Neoplastic Pericarditis (2005) (2)
Simultaneous Doppler and thermodilution assessment of pulmonary artery flow during acute interventions in patients with chronic obstructive pulmonary disease. (1990) (2)
[A case of a patient with idiopathic pulmonary arterial hypertension treated with lung transplantation: a "bumpy road" to success]. (2006) (2)
P116 Effects of macitentan on right ventricular remodeling in pulmonary arterial hypertension – results from the REPAIR study interim analysis (2019) (2)
Primary Sjögren's Syndrome with two extraglandular sites involvement - case report. (2010) (2)
[Pulmonary thromboembolism as a late complication of mitochondrial myopathy (Kearns-Sayer syndrome ]. (2003) (2)
[Neoplastic pericarditis--the role of different diagnostic procedures]. (2006) (2)
Effect of macitentan on haemodynamics in patients with pulmonary arterial hypertension: results from the long-term, randomised, placebo-controlled SERAPHIN trial (2013) (2)
[LGM inferior vena cava filters--observation of 79 patients]. (2000) (2)
[Chest ultrasound in the diagnosis of pulmonary embolism in a pregnant patient - a case report]. (2009) (2)
[A statement the Polish Cardiac Society Working Group on Pulmonary Circulation on screening for CTEPH patients after acute pulmonary embolism]. (2017) (2)
[Wegener's granulomatosis presenting with ischaemic stroke]. (2008) (2)
Subcutaneous treprostinil for the treatment of severe, non-operable chronic thromboembolic pulmonary hypertension: a randomized, double-blind, controlled study (CTREPH) (2013) (2)
[Statement on the diagnosis and treatment of tobacco dependence in patients with cardiovascular diseases]. (2011) (2)
[Role amiodarone in sinus rhythm maintenance after successful cardioversion in patients with chronic non-valvular atrial fibrillation]. (2002) (2)
Clinical meaning of low DLCO in idiopathic pulmonary arterial hypertension (IPAH) - Prospective single centre study (2015) (1)
[Inhaled nitric oxide (NO) for vasoreactivity testing in pulmonary hypertension]. (2004) (1)
Case report Vascular complications in a 51-year-old female with a primary antiphospholipd syndrome – a case report (2007) (1)
[Differential diagnosis of pneumonia and pulmonary embolism]. (2002) (1)
[Right ventricle structure and function in patients with obstructive sleep apnea (OSA)]. (2004) (1)
[Medical treatment in chronic thromboembolic pulmonary hypertension]. (2010) (1)
Outcomes of COVID-19 in patients vaccinated and unvaccinated against SARS-CoV-2 and suffering from pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. (2023) (1)
Echocardiographic findings in pulmonary hypertension (2018) (1)
Powikłania naczyniowe u 51-letniej chorej z pierwotnym zespołem antyfosfolipidowym - opis przypadku Vascular complications in a 51-year-old female with a primary antiphospholipd syndrome - a case report (2007) (1)
[Clinical picture of pulmonary embolism]. (1982) (1)
Recurrent exudative pericarditis in the course of adult-onset Still’s disease — two case reports (2011) (1)
An expert opinion of the Polish Cardiac Society Working Group on Pulmonary Circulation on screening for CTEPH patients after acute pulmonary embolism: Update. (2022) (1)
Acquired methaemoglobinaemia — a case report (2010) (1)
RHYTHM OR RATE CONTROL FOR PERSISTENT ATRIAL FIBRILLATION: RESULTS OF LONG TERM FOLLOW-UP OF THE HOT CAFE STUDY POPULATION. (2012) (1)
[Pulmonary thrombendarterectomy in treatment of patients with chronic thromboembolic pulmonary hypertension]. (2000) (1)
The importance of psychosocial factors in management of pulmonary arterial hypertension patients. (2018) (1)
Foreword: right ventricular function and pulmonary hypertension (2007) (1)
Aortic root abscess--echocardiographic image. (1988) (1)
[Diagnostic difficulties in primary mesothelioma]. (2008) (1)
[Differences in hemodynamics of thromboembolic and primary pulmonary hypertension]. (2000) (1)
S47 Effect of macitentan on haemodynamics in patients with pulmonary arterial hypertension: results from the long-term, randomised, placebo-controlled SERAPHIN trial (2013) (1)
[Non-invasive methods for determining the pulmonary blood pressure using ultrasonics in patients with chronic respiratory diseases]. (1991) (1)
[Effect of localization of pulmonary arterial changes on echocardiographic indices of right heart function and their correlation with exercise capacity: comparison of arterial and thromboembolic pulmonary hypertension]. (2004) (1)
Transesophageal echocardiography in the definition of intracardiac sources of emboli in patients with recent ischemic stroke. (1990) (1)
Polish Forum for Prevention: a response to the European Society of Cardiology ‘call for action’ in Poland (2010) (1)
Milestones in Understanding Pulmonary Circulation: From Antiquity to Heart-Lung Machine (2021) (1)
Noninvasive Assessment of Pulmonary Arterial Pressure with Ultrasound (1993) (1)
[Noninvasive evaluation of blood pressure in the pulmonary artery using a Doppler method]. (1987) (1)
European Society of Cardiology quality indicators for the care and outcomes of adults with pulmonary arterial hypertension. Developed in collaboration with the Heart Failure Association of the European Society of Cardiology (2023) (1)
Macitentan for treatment of CTEPH: why MERIT merits attention. (2017) (1)
RIGHT HEART THROMBI EUROPEAN REGISTRY (2015) (1)
EFFECT OF MACITENTAN ON HEMODYNAMICS IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: Results FROM THE LONG-TERM, RANDOMISED, PLACEBO-CONTROLLED SERAPHIN TRIAL (2014) (1)
839 Can plasma NTproBNP assess right ventricular overload in patients with acute pulmonary embolism (2003) (1)
Prognostic value of pulmonary function testing in idiopathic pulmonary hypertension - The most relevant differences between survivors and non-survivors in three-years observation study (2012) (1)
The risk of respiratory failure for chronic thromboembolic pulmonary hypertension patients after pulmonary endarterectomy (2011) (1)
L-arginine supplementation in pulmonary arterial hypertension (2004) (1)
[Evaluation of 24-hour ambulatory ECG recording in patients with mitral valve prolapse]. (1990) (1)
[Pulmonary embolism in course of deep vein thrombosis of lower extremities in patient wit bilateral femoral bone fracture after car accident injuries]. (2002) (1)
Prostacyclin analogues decrease platelet aggregation but have no effect on thrombin generation, fibrin clot structure, and fibrinolysis in pulmonary arterial hypertension: PAPAYA coagulation (2022) (1)
[Thrombo-embolic pulmonary hypertension--do not spoil a chance for effective surgery!]. (2011) (1)
Acute coronary syndrome caused by compression of the left main coronary artery – the usefulness of computed tomography in diagnosis and interventional treatment planning (2012) (1)
[Unusual cause of right heart failure decompensation in 21-years old patient with idiopathic pulmonary arterial hypertension -- a case report]. (2007) (1)
cooperative pulmonary embolism registry Right heart thrombi in pulmonary embolism: Results from the international (2011) (0)
Thrombolysis in submassive pulmonary embolism (2004) (0)
[Usefulness of measuring levels of d-dimer for diagnosis of hospital venous thromboembolism]. (2000) (0)
Vena cava superior stenting for rescue treatment of critical stenosis related to progressing cancer disease. (2016) (0)
Characteristics and Outcomes of Patients Consulted by a Multidisciplinary Pulmonary Embolism Response Team: 5-Year Experience (2022) (0)
Echocardiography: diagnostic and prognostic value in the assessment of pulmonary embolism (2004) (0)
Sarcoidosis-associated pulmonary hypertension treated with sildenafil (2017) (0)
Subject Index Vol. 107, 2007 (2006) (0)
An unusual case of CTEPH treated by BPA in a patient with a single lung after cancer surgery (2022) (0)
Baseline characteristics of patients included into the ERS Clinical Research Collaboration: “Pulmonary Hemodynamics during Exercise - Research Network” (PEX-NET) registry (2022) (0)
Is 6-minute walk distance (6MWD) associated with long-term outcomes in pulmonary arterial hypertension (PAH)? Results from SERAPHIN (2013) (0)
[Mycobacterium kansasii infection in chronic thromboembolic pulmonary hypertension (CTEPH), report of two cases]. (2008) (0)
Diagnostic aspects of pulmonary embolism (2004) (0)
Does a successful cardioversion of chronic non‐valvular atrial fibrillation always improve left ventricular ejection fraction? A long term echocardiographic study (2000) (0)
Chapter 64 Pulmonary embolism (2010) (0)
Effect of riociguat on pulmonary arterial compliance (PAC) in patients with PAH in PATENT-1 (2015) (0)
[Pulmonary embolism--at the beginning of a new age]. (2000) (0)
Letters to the Editor More on Right Atrial Mobile Thrombi (0)
Pulmonary Artery Dilatation Correlates With The Risk Of Sudden Death In Chronic Pulmonary Hypertension (2011) (0)
In Reply: The Role of NT-proBNP as a Prognostic Marker in Pulmonary Hypertension (2006) (0)
[Echocardiography improves the chance of conclusive results in spiral computed tomography of suspected pulmonary embolism]. (2000) (0)
64 Assessment of the right ventricular (RV) function by Doppler tissue imaging (TDI) in patients with pulmonary arterial hypertension (PAH) (2004) (0)
526: ENOS Polymorphisms and 6MWD Interactions in PAH Patients on Endothelin Antagonists (2009) (0)
[Pulmonary embolism: the past and . . . the future]. (2001) (0)
[Things are not as bad as they seen]. (2011) (0)
Cardiac Troponin T Monitoring and Acute Pulmonary Embolism: Nothing Has Changed (2004) (0)
Comparison of disopyramide, propafenone and sotalol after direct current cardioversion of chronic atrial fibrillation (1997) (0)
[Pulmonary hypertension--management strategies]. (2003) (0)
Pulmonary Hypertension: Diagnosis and Management (2021) (0)
[Echocardiographic evaluation of left ventricular function in patients with pheochromocytoma]. (1984) (0)
More on right atrial mobile thrombi. (1997) (0)
463 Visualization of pulmonary arteries during transesophageal echocardiography (1999) (0)
P2604A long-term outcome of patients with chronic thromboembolic pulmonary hypertension treated with different methods (2017) (0)
[Vascular complications in a 51-year-old female with a primary antiphospholipd syndrome--a case report]. (2007) (0)
A Meta-analysis: Outcomes in Patients With Pulmonary Arterial Hypertension (PAH) Associated With Congenital Heart Disease (CHD) Receiving PAH Medication (2023) (0)
[Infective endocarditis in a patient with multiple myeloma. A case report]. (2005) (0)
Pattern of Systemic Venous Return during Negative Pressure Ventilation with Pneumowrap: A Pulsed Wave Doppler Study in Patients with COPD (1991) (0)
Relationship between exercise tolerability and the dynamism of changes of selected echocardiographic parameters during long‐term observation in patients with chronic atrial fibrillation (2000) (0)
[Echocardiographic picture in a case of pulmonary embolism with subacute course]. (1983) (0)
Recovery of right ventricular function after intermediate-risk pulmonary embolism: results from the multicentre Pulmonary Embolism International Trial (PEITHO)-2. (2022) (0)
Ominous prognostic implications and inadequacy of heparin alone for right heart thrombi in patients with acute pulmonary embolism: analysis of baseline characteristics, echocardiograms, treatment, and clinical outcomes in the International Cooperative Pulmonary Embolism Registry (2002) (0)
[ST-T changes in artificially stimulated ventricular complexes in fresh acute myocardial infarct]. (1979) (0)
Effect of macitentan on morbidity and mortality in pulmonary arterial hypertension: A randomised controlled trial (SERAPHIN) (2013) (0)
Idiopathic venous thromboembolism or occult cancer (2014) (0)
Anomalous inferior vena cava mimicking aortic dissection on transesophageal echocardiography (1993) (0)
649 Restoration of sinus rhythm decreases the incidence of left atrial spontaneous echocardiographic contrast in patients with chronic nonrheumatic atrial fibrillation: An echocardiographic study (1999) (0)
Acute pulmonary embolism with coexisting right heart thrombi in transit-surgical treatment of 20 consecutive patients. (2023) (0)
From Endothelin to Endothelin Receptor Antagonism: An Innovative Approach to Pulmonary Arterial Hypertension (2003) (0)
[Left-ventricular function in diabetes mellitus type 1 not complicated by cardiovascular diseases]. (1988) (0)
[Interstitial pneumonitis in a patient treated with amiodarone -- case report]. (2008) (0)
Role of Oxygen Starvation in Right Ventricular Decompensation and Failure in Pulmonary Arterial Hypertension. (2023) (0)
Effect of riociguat on pulmonary arterial compliance (PAC) in patients with CTEPH in the CHEST-1 study (2015) (0)
Using controlled and real-world data in concert to assess survival in pulmonary arterial hypertension: Insights from SERAPHIN and REVEAL (2018) (0)
Hypertension Pulmonary Hypertension Diagnosis, Assessment, and Treatment of Non-Pulmonary Arterial (2010) (0)
Hypoxia Pulmonary Arterial Hypertension : Results of a Multicenter European Analysis of Stress Doppler Echocardiography in Relatives of Patients With Idiopathic and Familial (2009) (0)
Determinants of Echo-Doppler Indices of Left Ventricular Filling in Patients with Chronic Lung Diseases (1992) (0)
Effect of macitentan on left ventricular (LV) function in pulmonary arterial hypertension (PAH): results from REPAIR (2020) (0)
[Feasibility of home self-administration of low molecular weight heparin by patients with atrial fibrillation recurrence. A new approach to thromboembolic prophyllaxis]. (2005) (0)
Percutaneous retrieval of a fractured portacath fragment in two patients undergoing long-term chemotherapy (2016) (0)
Hypoperfusion is the main risk factor for the development of non-tuberculous mycobacterial lung disease in CTEPH (2013) (0)
Case-based session: see this case at least once: Saturday 6 December 2014, 10:00-11:00 * Location: Agora (2014) (0)
[Constrictive pericarditis as complication of viral respiratory infection]. (2012) (0)
P2600Replacement sildenafil by riociugat in patients with inoperable or persistent chronic thromboembolic pulmonary hypertension improves exercise capacity and hemodynamics (2017) (0)
Chronic thromboembolic pulmonary hypertension and idiopathic pulmonary hypertension are the conditions predisposing to non-tuberculous mycobacterial lung disease (NTMLD) (2011) (0)
Cardiac troponins in acute pulmonary embolism. Author's reply (2002) (0)
Do Parameters of Cardiac Function Predict Long-term Outcomes in Patients With Pulmonary Arterial Hypertension? Data From SERAPHIN, a Randomized Controlled Study of Macitentan (2013) (0)
[Size of the left atrium--comparison of echocardiographic and electrocardiographic criteria]. (1978) (0)
Case report Infective endocarditis in a patient with multiple myeloma. A case report (2005) (0)
Atrial Septostomy (2021) (0)
[Right-atrial thrombi: their etiology, diagnosis and management]. (1988) (0)
[Treatment of primary pulmonary hypertension with high doses of nifedipine controlled by Doppler echocardiography]. (1991) (0)
[Adaptation of the left ventricle to increased load in primary arterial hypertension]. (1990) (0)
Myocardial dysfunction related to trastuzumab therapy – is effective treatment always possible? (2014) (0)
Long-Term Safety, Tolerability and Survival in Patients with Pulmonary Arterial Hypertension Treated with Macitentan: Results from the SERAPHIN Open-Label Extension (2022) (0)
278 Impact of rate versus rhythm control strategy on left ventricle function in patients with persistent atrial fibrillation, one year follow-up (2005) (0)
215 The value of echocardiographic test with nitric oxide (NO) in assessment of vasodilator responsiveness in patients with idiopathic pulmonary arterial hypertension (IPAH) (2005) (0)
P2-121: Coagulation/fibrinolysis activation in advanced non small cell lung cancer: tumor invasion or venothrombotic complication (2007) (0)
COMPARISON OF STANDARDIZED TREATMENT EFFECT SIZES FOR INVASIVE AND NON-INVASIVE ENDPOINTS IN PULMONARY ARTERIAL HYPERTENSION: INSIGHTS FROM THE REPAIR STUDY (2021) (0)
[Echocardiographic image of a pedunculated thrombus in the right atrium in a patient with pulmonary embolism]. (1985) (0)
The Right Heart and Pulmonary Circulation ( VI ) Pulmonary Thromboembolic Disease . Clinical Management of Acute and Chronic Disease (2018) (0)
Cancer associated thrombosis: comparison of characteristics, treatment, and outcomes in oncological and non-oncological patients followed by Pulmonary Embolism Response Team. (2023) (0)
Centrilobular nodules are combined with lack of PFO and worse haemodynamic profile in IPAH patients (2016) (0)
Primary Sjögren's syndrome with two extraglandular sites involvement — case report Zespół Sjögrena z zajęciem dwóch narządów pozawydzielniczych — opis przypadku (2010) (0)
[Acquired methemoglobinemia--case report]. (2010) (0)
[Scimitar syndrome--case report]. (2004) (0)
MACITENTAN TREATMENT EFFECT IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION TAKING SPIRONOLACTONE: POST-HOC ANALYSIS OF THE PHASE 3 SERAPHIN TRIAL (2021) (0)
Lung transplantation in patients with pulmonary arterial hypertension: The opinion of the Polish Cardiac Society Working Group on Pulmonary Circulation. (2022) (0)
[Diagnosis of congenital anomaly of the inferior vena cava simulating aortic dissecting aneurysm by the method of transesophageal echo- cardiography]. (1992) (0)
REPAIR: long-term effects of macitentan on the right ventricle (RV) in pulmonary arterial hypertension (PAH) (2020) (0)
[Lung transplantation for end-stage pulmonary hypertension]. (2004) (0)
PULMONARY EMBOLISM : FROM SYMPTOMS TO DIAGNOSIS (1997) (0)
[Minipress in congestive heart failure]. (1985) (0)
[Pulmonary thrombendarterectomy in a patient with chronic thromboembolic pulmonary hypertension (CTEPH) and chronic renal failure due to diabetic nephropathy--case report]. (2004) (0)
Prognostic significance of right heart thrombi (RHT) in patients with acute symptomatic pulmonary embolism: Systematic review and meta-analysis (2016) (0)
[Natural history of pulmonary hypertension in chronic obstructive lung diseases and the usefulness of the simple noninvasive methods of its diagnosis]. (1992) (0)
838Direct measurement of left ventricular outﬂow tract by newly developed transthoracic real-time-3D-echocardiography increases accuracy in assessment of aortic valve stenosis. prevention in patients according technique: an study on (2004) (0)
[Lung function and exercise tolerance in patients with chronic major vessel thromboembolic pulmonary hypertension]. (1996) (0)
Clinical practice guidelines of the ESC on myocardial revascularization, 2014 (2015) (0)
[Pulmonary hypertension--some problems resolved. More remain to be solved]. (2004) (0)
Special article Acute pulmonary embolism – new target for interventional cardiology? (2006) (0)
Noninvasive Tools to Monitor Pulmonary Hypertension (2007) (0)
[Transesophageal echocardiography--a method for prompt diagnosis of acute hemodynamically significant pulmonary embolism]. (2000) (0)
P5421Is soluble supression of tumorigenicity (sST2) a new biomarker in patients with right ventricular failure due to pulmonary hypertension (2017) (0)
Results ESC Board Elections 2010 - 2012 (2012) (0)
[Advances in the diagnosis and treatment of pulmonary embolism]. (1987) (0)
EFFECT OF MACITENTAN ON CARDIAC FUNCTION IN PULMONARY ARTERIAL HYPERTENSION: RESULTS FROM THE REPAIR ECHOCARDIOGRAPHY SUBSTUDY (2020) (0)
Outcome Of Pregnancies In Women With Pulmonary Arterial Hypertension In The Modern Management Era (2011) (0)
[Echocardiographic picture of neoplastic pericardial infiltration]. (1980) (0)
[Thrombectomy in a patient with a mobile clot in the inferior vena cava--case report]. (2000) (0)
Valves in the Heart of the Big Apple V: Evaluation and Management of Valvular Heart Diseases 2007.Third Annual Scientific Session: Heart Valve Society of America, New York City, N.Y., April 12–14, 2007 (2007) (0)
Assessment of Clinical Usefulness of Resting Electrocardiogram (PH-ECG Score) in Monitoring the Efficacy of Balloon Pulmonary Angioplasty (BPA) in Patients with Chronic Thromboembolic Pulmonary Hypertension (CTEPH) (2021) (0)
Compendium of Abridged ESC Guidelines 2011 (2012) (0)
Response to letter from dr Altmayer regarding publication "Sequential treatment with sildenafil and riociguat in patients with persistent or inoperable chronic thromboembolic pulmonary hypertension improves functional class and pulmonary hemodynamics". (2019) (0)
Does Sitaxsentan Therapy Offer Benefit To Functional Class II Patients With Pulmonary Arterial Hypertension (2010) (0)
Predictive value of chest HRCT for survival in idiopathic pulmonary arterial hypertension (2021) (0)
Diagnosis and Assessment of Pulmonary Arterial Hypertension: A Glance at the Output From the Dana Point Conference (2009) (0)
Relationship between the left ventricle shortening fraction value and dynamism changes of selected echo parameters during a one year observation period in patients with chronic atrial fibrillatin (2000) (0)
TCT-804 Improvement in the balloon pulmonary angioplasty strategy results in reduction of periprocedural complications and mortality rate. (2016) (0)
S93 REPAIR: long-term effects of macitentan on the right ventricle (RV) in pulmonary arterial hypertension (PAH) (2021) (0)
[Use of temporal vena cava filter in a patient with a high risk of perioperative pulmonary embolism]. (2000) (0)
Echocardiography in acute pulmonary embolism (2005) (0)
[Pulmonary hypertension in contemporary imaging. Expert consensus statement of the Polish Clinical Forum for Cardiovascular Imaging]. (2014) (0)
Guidelines on the identification and treatment of pulmonary hypertension. (2009) (0)
[Clinical course of familial primary pulmonary hypertension in a 39-year-old female and her two children]. (2009) (0)
A 35-year old man with dyspnea on exertion, history of acute pulmonary embolism and ischaemic stroke (2012) (0)
Should a diagnosis of cancer impact the anticoagulant therapy in patients with recurrent thromboembolic disease (2015) (0)
Acute Pulmonary Embolism 2008 (2012) (0)
Contents Vol. 107, 2007 (2006) (0)
[Advances in pulmonology in year 2012]. (2013) (0)
SAFETY AND EFFICACY OF MACITENTAN IN ELDERLY PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION (PAH): INSIGHTS FROM SERAPHIN (2020) (0)
Pulmonary arterial hypertension-related morbidity is prognostic for survival: Insights from the SERAPHIN and GRIPHON studies (2017) (0)
Ultrasonografia klatki piersiowej w diagnostyce zatorowości płucnej u ciężarnej — opis przypadku Chest ultrasound in the diagnosis of pulmonary embolism in a pregnant patient — a case report (2009) (0)
[Right-atrial thrombi: report of 2 cases treated with a fibrinolytic drug]. (1988) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Adam Torbicki?

Adam Torbicki is affiliated with the following schools: